GFAP and obesity due to melanocortin 4 receptor deficiency: To evaluate whether obesity-induced glial activation is affected by NIR treatment, we analyzed the immunoreactive levels of Iba-179,80 (microglia marker), CD68 (detects activated microglia80), and GFAP (astrocyte marker)81.